RxDoctor Payments Data

Anjani Narra, MD

Psychiatry · Baton Rouge, LANPI 1285795716

Payments from drug & device makers

$3,837in general payments, 2019–2025

Across 200 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$555
  • Neurocrine Biosciences, Inc.$477
  • Indivior Inc.$477
  • Teva Pharmaceuticals USA, Inc.$399
  • AbbVie$369
  • Sunovion Pharmaceuticals Inc.$339
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$3,74298%
  • Education$952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,837 in reported general payments places this provider in the 80th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana

Medicare billing

Part B allowed, 2024
$3,413
Medicare patients
15
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate37$302,783
Invega SustennaPaliperidone Palmitate64$200,365
Oxcarbazepine75$2,927
Aripiprazole76$2,280
Lurasidone Hcl53$1,351
Quetiapine Fumarate122$1,344
Divalproex Sodium ErDivalproex Sodium51$1,167
Buspirone Hcl83$1,005
Prazosin Hcl43$906
Sertraline Hcl90$896
Benztropine Mesylate93$861
Trazodone Hcl93$797
Olanzapine54$692
Haloperidol24$669
Divalproex Sodium58$634

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$477$302,78337 claims
Johnson & JohnsonInvega Sustenna$302$200,36564 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 474 psychiatry providers in Louisiana.

Other psychiatry in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →